scholarly journals Exploratory Assessment of Oxygen Flow–Assisted Cutaneous Administration of Methotrexate for Superficial Basal Cell Carcinoma, Mycosis Fungoides, and Extramammary Paget Disease

2020 ◽  
Vol 140 (3) ◽  
pp. 583-592 ◽  
Author(s):  
Eve Lebas ◽  
Corinne Chapelier ◽  
Pascale Quatresooz ◽  
Laurence Seidel ◽  
A.F. Nikkels
2005 ◽  
Vol 31 (2) ◽  
pp. 217-220 ◽  
Author(s):  
KETTY PERIS ◽  
ANGELA FERRARI ◽  
MARIA CONCETTA FARGNOLI ◽  
DOMENICO PICCOLO ◽  
SERGIO CHIMENTI

2016 ◽  
Vol 28 (6) ◽  
pp. 796 ◽  
Author(s):  
Yu Seok Jung ◽  
Ji Hae Lee ◽  
Jung Min Bae ◽  
Gyong Moon Kim

2021 ◽  
Author(s):  
Natalie Kash ◽  
Sirunya Silapunt

Although surgical therapy continues to be the gold standard for the treatment of basal cell carcinoma given high cure rates and the ability to histologically confirm tumor clearance, there are a number of nonsurgical treatment options that may be considered based on individual tumor characteristics, functional and cosmetic considerations, patient comorbidities and patient preference. Topical 5-fluorouracil 5% cream and imiquimod 5% cream have been US FDA-approved for the treatment of superficial basal cell carcinoma. Additionally, a number of new and emerging topical agents and techniques have been described for the treatment of basal cell carcinoma and will be reviewed herein.


Sign in / Sign up

Export Citation Format

Share Document